Centogene (CNTGF, $0.15) was a top loser yesterday, declining -1 to $0.15 per share. Of the 396 stocks analyzed in the Medical Specialties Industry, of them () exhibited an Uptrend while of them () were in a Downtrend.
a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies